vimarsana.com

சிறிய மூலக்கூறு மருந்து கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Syngene extends drug discovery research collaboration with BMS until 2030

Syngene extends drug discovery research collaboration with BMS until 2030 Syngene extends drug discovery research collaboration with BMS until 2030 27 April 2021 | News The extension envisions a 40% increase in the number of scientists and the addition of a new 50,000 sq. ft. dedicated laboratory space Image credit- shutterstock.com Syngene International, an integrated research, development and manufacturing services company, has announced that it has extended its ongoing research collaboration with Bristol Myers Squibb (BMS). The collaboration has been extended through the end of 2030 and will expand the breadth of drug discovery research conducted, including chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemical process development and analytical sciences, in the coming years.

Syngene extends research collaboration with Bristol Myers Squibb

Syngene extends research collaboration with Bristol Myers Squibb April 27, 2021 Tie up to extend through the end of 2030 Syngene International, an integrated research, development and manufacturing services company, has announced that it has extended its ongoing research collaboration with Bristol Myers Squibb. The collaboration has been extended through the end of 2030 and will expand the breadth of drug discovery research conducted, including chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemical process development and analytical sciences, in the coming years. The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000 sq ft dedicated laboratory space.

Global Small-Molecule Drug Discovery Market Insights Report 2021, Trends & Opportunities to 2026|Pfizer, Teva Pharmaceuticals, GlaxoSmithKline, Merck, Johnson & Johnson, etc – KSU

Primary worldwide  Global Small-Molecule Drug Discovery  Market manufacturing companies, to specify, clarify and analyse the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans for future. To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. Does this report provide customization? Customization helps organizations gain insight into specific market segments and areas of interest. Therefore, Market Info Reports provides customized report information according to business needs for strategic calls. Get Customization of the Report@: Why Choose Market Info Reports?: Market Info Reports Research delivers strategic market research reports, industry analysis, statistical surveys and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SME’s, individuals and Start-ups,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.